| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a safer and more sustainable gene delivery system or the like, which is effective for treatment of ischemic diseases and the like. <P>SOLUTION: There is disclosed a pharmaceutical composition which includes, as an active ingredient, a polyanionic substance that inhibits the expression of PHD2, and includes a polyion complex of the polyanionic substance and a polycationically charged polymer. <P>COPYRIGHT: (C)2011,JPO&INPIT |
